Multivariate Pharma Technology Transfer Analysis: Civilization Diseases and COVID-19 Perspective

The importance of studying civilization diseases manifests itself in the impact of changing lifestyles, on the number of deaths and causes of death. Technology transfer plays an important role in the prevention and treatment of these diseases. Through this, it is possible to transfer new treatments and diagnostics to clinics and hospitals more quickly and effectively, which leads to better healthcare for patients. Technology transfer can also aid in the development of new drugs and therapies that can be effective in the treatment of civilization diseases. The paper aims to evaluate the technology transfer process in the field of civilization diseases, using COVID-19 as an example of a pandemic that requires quick development and transfer of technology. To achieve the assumed goal, we propose a multivariate synthetic ratio in the field of civilization diseases (SMTT—Synthetic Measure of Technology Transfer) to analyze data from the Global Data database. We used sub-measures like SMTT_value (Synthetic Measure of Technology Transfer_value) and SMTT_quantity (Synthetic Measure of Technology Transfer_quantity) to measure technology transfer and put the data into a graph. Our analysis focuses on 14 diseases over a period of 10 years (2012–2021) and includes nine forms of technology transfer, allowing us to create a tool for analysing the process in multiple dimensions. Our results show that COVID-19 is similar in terms of technology transfer to diseases such as diabetes, cardiovascular diseases, neurodegenerative diseases, and breast cancer, even though data for COVID-19 is available for only 2 years.

[1]  Yifei Su,et al.  Diabetes Mellitus risk prediction using age adaptation models , 2023, Biomed. Signal Process. Control..

[2]  P. Jennings,et al.  Technology transfer from national/federal labs and public research institutes: Managerial and policy implications , 2023, Research Policy.

[3]  M. Brzeziński,et al.  Childhood Obesity: Position Statement of Polish Society of Pediatrics, Polish Society for Pediatric Obesity, Polish Society of Pediatric Endocrinology and Diabetes, the College of Family Physicians in Poland and Polish Association for Study on Obesity , 2022, Nutrients.

[4]  Daniel A. McFarland,et al.  Systematic analysis of 50 years of Stanford University technology transfer and commercialization , 2022, Patterns.

[5]  P. Reddy,et al.  The Role of Obesity and Diabetes in Dementia , 2022, International journal of molecular sciences.

[6]  D. P. Lacerda,et al.  Vaccine innovation model: A technology transfer perspective in pandemic contexts , 2022, Vaccine.

[7]  E. Petlenkov,et al.  Bridging the Gap in Technology Transfer for Advanced Process Control with Industrial Applications , 2022, Sensors.

[8]  Amol M. Joshi,et al.  Exploring the role of R&D collaborations and non-patent IP policies in government technology transfer performance: Evidence from U.S. federal agencies (1999–2016) , 2022, PloS one.

[9]  Yuqi Lu,et al.  The Impact of Ecological Civilization Construction on Environment and Public Health—Evidence from the Implementation of Ecological Civilization Demonstration Area in China , 2022, International journal of environmental research and public health.

[10]  M. Nuijten.  Pricing Zolgensma – the world’s most expensive drug , 2021, Journal of market access & health policy.

[11]  R. Pagani,et al.  Fundamental elements in Technology Transfer: an in-depth analysis , 2021, Technol. Anal. Strateg. Manag..

[12]  Vijay Kumar Chattu,et al.  Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 , 2021, JAMA oncology.

[13]  Laura Alessandretti.  What human mobility data tell us about COVID-19 spread , 2021, Nature reviews. Physics.

[14]  Xiaolan Fu,et al.  The world has a unique opportunity: Accelerating technology transfer and vaccine production through partnerships , 2021, Journal of International Business Policy.

[15]  V. Bucciarelli,et al.  Depression pandemic and cardiovascular risk in the COVID-19 era and long COVID syndrome: Gender makes a difference , 2021, Trends in Cardiovascular Medicine.

[16]  E. Carayannis,et al.  Helix Trilogy: the Triple, Quadruple, and Quintuple Innovation Helices from a Theory, Policy, and Practice Set of Perspectives , 2021, Journal of the Knowledge Economy.

[17]  R. Cooper,et al.  TECHNOLOGY TRANSFER ASSISTANCE PROJECT BRINGS VA HEALTH CARE IDEAS TO LIFE. , 2021, Technology and innovation.

[18]  M. Yip.  We have never been so bounded: Pandemic, territoriality, and mobility , 2021, The Geographical journal.

[19]  G. Katul,et al.  Intensity and frequency of extreme novel epidemics , 2021, Proceedings of the National Academy of Sciences.

[20]  S. Dutta,et al.  Impact of lifestyle diseases on income and household consumption: evidence from an emerging economy , 2021, Health marketing quarterly.

[21]  J. Bongaarts,et al.  United Nations Department of Economic and Social Affairs, Population Division World Family Planning 2020: Highlights, United Nations Publications, 2020. 46 p. , 2020 .

[22]  Anne Sachet-Milliat,et al.  Cure or Sell: How Do Pharmaceutical Industry Marketers Combine Their Dual Mission? An Approach Using Moral Dissonance , 2020, Journal of Business Ethics.

[23]  Worawith Sangkatip,et al.  Non-Communicable Diseases Classification using Multi-Label Learning Techniques , 2020, 2020 - 5th International Conference on Information Technology (InCIT).

[24]  James A. Cunningham,et al.  The brokering role of technology transfer offices within entrepreneurial ecosystems: an investigation of macro–meso–micro factors , 2020, The Journal of Technology Transfer.

[25]  Leora I. Horwitz,et al.  Trends in Covid-19 risk-adjusted mortality rates in a single health system , 2020, medRxiv.

[26]  V. Ratten,et al.  Technological transfer and spillovers within the RIS3 entrepreneurial ecosystems: a quadruple helix approach , 2020, Knowledge Management Research & Practice.

[27]  Prasenjit Maity,et al.  COVID-19 outbreak: Migration, effects on society, global environment and prevention , 2020, Science of The Total Environment.

[28]  Federica Cariati,et al.  From laboratory bench to benchmark: technology transfer in laboratory medicine , 2020, Annals of translational medicine.

[29]  R. Pagani,et al.  Government Initiative in Brazilian Public Health: A Technology Transfer Analysis , 2019, International journal of environmental research and public health.

[30]  Ziyuan Sun,et al.  How Can We Improve the Transformation Success Rate of Research Results in the Pharmaceutical Industry? The Game Theoretic Model of Technology Transfer Subjects , 2019, International journal of environmental research and public health.

[31]  A. Roșeanu,et al.  Diseases of Civilization - Cancer, Diabetes, Obesity and Acne - the Implication of Milk, IGF-1 and mTORC1. , 2018, Maedica.

[32]  Ivan Rusyn,et al.  Technology Transfer of the Microphysiological Systems: A Case Study of the Human Proximal Tubule Tissue Chip , 2018, Scientific Reports.

[33]  Courtney M. Sakolish,et al.  Technology Transfer of the Microphysiological Systems: A Case Study of the Human Proximal Tubule Tissue Chip , 2018, Scientific Reports.

[34]  ICD,et al.  WHO releases new International Classification of DISEASES (ICD 11) , 2018, Saudi Medical Journal.

[35]  Nathan L. Vanderford,et al.  Evaluating disparities in the U.S. technology transfer ecosystem to improve bench to business translation , 2018, F1000Research.

[36]  Katarzyna Sygit.  Health problems of seniors: selected diseases of the old age , 2018 .

[37]  James H. Ford,et al.  Testing the implementation and sustainment facilitation (ISF) strategy as an effective adjunct to the Addiction Technology Transfer Center (ATTC) strategy: study protocol for a cluster randomized trial , 2017, Addiction Science & Clinical Practice.

[38]  A. Pacian,et al.  LYME BORRELIOSIS AS A CURRENT HEALTH PROBLEM OF THE 21 ST CENTURY , 2017 .

[39]  S. Terry,et al.  Review of 11 national policies for rare diseases in the context of key patient needs , 2017, Orphanet Journal of Rare Diseases.

[40]  D. Ockwell,et al.  Improving technology transfer through national systems of innovation: climate relevant innovation-system builders (CRIBs) , 2016 .

[41]  Mickell Branham.  Listening to Victims, in Death Penalty and the Victims, United Nations Human Rights Office of the High Commissioner , 2016 .

[42]  C. Bausewein,et al.  Physical compared to mental diseases as reasons for committing suicide: a retrospective study , 2016, BMC Palliative Care.

[43]  Z. Wyszkowska.  Wybrane koszty społeczne chorób cywilizacyjnych na przykładzie astmy i cukrzycy , 2016 .

[44]  Andreana Casaramona,et al.  How TOI and the Quadruple and Quintuple Helix Innovation System Can Support the Development of a New Model of International Cooperation , 2015 .

[45]  Karol Śledzik,et al.  Zastosowanie syntetycznych miar do konstrukcji Mapy Pozycji Konkurencyjnej przedsiębiorstw w aspekcie wydatków na B+R i wyniku finansowego , 2015 .

[46]  G. Schmitz,et al.  Milk consumption during pregnancy increases birth weight, a risk factor for the development of diseases of civilization , 2015, Journal of Translational Medicine.

[47]  A. Oniszczuk,et al.  Obesity and poverty paradox in developed countries. , 2014, Annals of agricultural and environmental medicine : AAEM.

[48]  C. Boog,et al.  Lessons learned during the development and transfer of technology related to a new Hib conjugate vaccine to emerging vaccine manufacturers. , 2014, Vaccine.

[49]  Karol Śledzik,et al.  Multidimensional Competitive Position Analysis of Most Innovative Pharmaceutical & Biotechnology Companies - 2012 Perspective , 2014 .

[50]  A. Davis,et al.  The entrepreneurial state: : debunking public vs. private sector myths , 2014 .

[51]  D. Dudek,et al.  Mental disorders in somatic diseases: psychopathology and treatment. , 2012, Polskie Archiwum Medycyny Wewnetrznej.

[52]  Raduan Che Rose,et al.  Defining the Concepts of Technology and Technology Transfer: A Literature Analysis , 2011 .

[53]  Mohammad Khalilia,et al.  Predicting disease risks from highly imbalanced data using random forest , 2011, BMC Medical Informatics Decis. Mak..

[54]  J. O’Keefe,et al.  The western diet and lifestyle and diseases of civilization , 2011 .

[55]  Morten T. Hansen,et al.  Knowledge Transfer in Intraorganizational Networks : Effects of Network Position and Absorptive Capacity on Business Unit Innovation and Performance , 2007 .

[56]  L. A. Salicrup,et al.  Challenges and opportunities for enhancing biotechnology and technology transfer in developing countries , 2005, Biotechnology Advances.

[57]  A. Skrzyńska,et al.  Jakość życia w chorobach przewlekłych / Anna Skrzyńska, Wiesław Skrzyński, Antoni Tomkiewicz. , 2006 .

[58]  Nicole Coviello,et al.  Methodological issues in international entrepreneurship research , 2004 .

[59]  R E Kendell,et al.  The distinction between mental and physical illness , 2001, British Journal of Psychiatry.

[60]  T. Scandura,et al.  Research Methodology In Management: Current Practices, Trends, And Implications For Future Research , 2000 .

[61]  T. Robinson.  The epidemic of pediatric obesity. , 2000, The Western journal of medicine.

[62]  Barry Bozeman,et al.  Technology transfer and public policy: a review of research and theory , 2000 .

[63]  L. Leydesdorff,et al.  The dynamics of innovation: from National Systems and , 2000 .

[64]  J. Kopczyński,et al.  Diseases of civilization, today and tomorrow , 1986 .

[65]  D. Burkitt,et al.  Some diseases characteristic of modern Western civilization. , 1973, British medical journal.

[66]  W. Wallis.  The Encyclopedia Britannica. , 1911 .

[67]  E. Hart.  Diet in Disease: XXII.-Under-Feeding and Overeating. , 1893 .

[68]  K. Shadan,et al.  Available online: , 2012 .